Annelies Verbon

8.8k total citations · 1 hit paper
227 papers, 5.5k citations indexed

About

Annelies Verbon is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Annelies Verbon has authored 227 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Epidemiology, 91 papers in Infectious Diseases and 41 papers in Virology. Recurrent topics in Annelies Verbon's work include HIV Research and Treatment (41 papers), HIV/AIDS Research and Interventions (30 papers) and Tuberculosis Research and Epidemiology (27 papers). Annelies Verbon is often cited by papers focused on HIV Research and Treatment (41 papers), HIV/AIDS Research and Interventions (30 papers) and Tuberculosis Research and Epidemiology (27 papers). Annelies Verbon collaborates with scholars based in Netherlands, United States and Sudan. Annelies Verbon's co-authors include Tom van der Poll, Peter Speelman, Sander J. H. van Deventer, Nicole P. Juffermans, A H Kolk, Sandrine Florquin, Thomas R. Hawn, Lue Ping Zhao, Bruce Beutler and Alan Aderem and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Annelies Verbon

220 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease

2003 467 citations Thomas R. Hawn, Annelies Verbon et al. profile →

Peers

Countries citing papers authored by Annelies Verbon

Since Specialization

Citations

This map shows the geographic impact of Annelies Verbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelies Verbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelies Verbon more than expected).

Fields of papers citing papers by Annelies Verbon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelies Verbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelies Verbon. The network helps show where Annelies Verbon may publish in the future.

Co-authorship network of co-authors of Annelies Verbon

This figure shows the co-authorship network connecting the top 25 collaborators of Annelies Verbon. A scholar is included among the top collaborators of Annelies Verbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelies Verbon. Annelies Verbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitro activity of antibiotic monotherapy and combination therapy with bacteriophages against Staphylococcus aureus LVAD-driveline infections 2025 ·Journal of Clinical Microbiology ·(unknown), Nelianne J. Verkaik, Corné P. de Vogel, Nicole Lemmens‐den Toom, Gwenan M. Knight, Kadir Çalişkan, L. Bode, Annelies Verbon, Marion Koopmans, Miranda de Graaf, Willem J. B. van Wamel	0
2	Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella 2025 ·Nature Communications ·Imad Abugessaisa, (unknown), Ri‐Ichiroh Manabe, C. K. Murphy, Tsugumi Kawashima, Akira Hasegawa, (unknown), Michihira Tagami, Yasushi Okazaki, Kimberly Eadie, Wilson Lim, Seán Doyle, Annelies Verbon, Ahmed Hassan Fahal, Takeya Kasukawa, Wendy W. J. van de Sande	0
3	Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial 2025 ·AIDS ·Carlijn Jordans, (unknown), Kara Osbak, (unknown), (unknown), (unknown), Natasja van Holten, (unknown), (unknown), (unknown), Jeroen J. A. van Kampen, Annelies Verbon, Anna H.E. Roukens, Casper Rokx	0
4	In Vitro and In Vivo Wide-Spectrum Dual Antimycetomal Activity of Eight Essential Oils Coupled with Chemical Composition and Metabolomic Profiling 2024 ·SHILAP Revista de lepidopterología ·(unknown), Prabodh Satyal, Naglaa S. Ashmawy, Annelies Verbon, Wendy W. J. van de Sande, Sami A. Khalid	3
5	Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study 2023 ·Journal of Medical Virology ·(unknown), (unknown), L. Marije Hofstra, Monique Nijhuis, Annelies Verbon, Tania Mudrikova, Annemarie M. J. Wensing, Andy I. M. Hoepelman, Berend J. van Welzen	3
6	Using a Madurella mycetomatis‐specific PCR on grains obtained via non‐invasive fine‐needle aspirated material is more accurate than cytology 2023 ·Mycoses ·Emmanuel Edwar Siddig, Ayman Ahmed, (unknown), Sahar Mubarak Bakhiet, Annelies Verbon, Ahmed Hassan Fahal, Wendy W. J. van de Sande	9
7	Quality of life among people living with HIV in England and the Netherlands: a population-based study 2021 ·The Lancet Regional Health - Europe ·Stephanie Popping, Meaghan Kall, Brooke E Nichols, (unknown), (unknown), David van de Vijver, Ard van Sighem, Matthijs Versteegh, Charles A. Boucher, Valérie Delpech, Annelies Verbon	29
8	Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment 2021 ·BMJ Open ·Maartje Dijkstra, Henrieke Prins, Jan M. Prins, Peter Reiss, Charles A. Boucher, Annelies Verbon, Casper Rokx, Godelieve de Bree	6
9	COVID outcome prediction in the emergency department (COPE): using retrospective Dutch hospital data to develop simple and valid models for predicting mortality and need for intensive care unit admission in patients who present at the emergency department with suspected COVID-19 2021 ·BMJ Open ·David van Klaveren, (unknown), Jelmer Alsma, (unknown), (unknown), Marlijn J. A. Kamps, Tom Dormans, (unknown), (unknown), (unknown), (unknown), Hilde R.H. de Geus, Rozemarijn L van Bruchem-Visser, Jelle Miedema, Annelies Verbon, Els van Nood, David M. Kent, Stephanie C. E. Schuit, Hester F. Lingsma	9
10	Study protocol for an international, multicentre stepped-wedge cluster randomised trial to evaluate the impact of a digital antimicrobial stewardship smartphone application 2020 ·BMJ Open ·(unknown), Gaud Catho, (unknown), Johan W. Mouton, Marlies Hulscher, Steven Teerenstra, John Conly, Benedikt Huttner, Thomas Tängdén, Annelies Verbon	5
11	Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study 2019 ·BMJ Open ·Marlies Mulder, (unknown), Annelies Verbon, Bruno H. Stricker, Katia Verhamme	23
12	The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans 2018 ·PLoS Pathogens ·(unknown), Lutz Hamann, Javeed A. Shah, Annelies Verbon, Frank P. Mockenhaupt, Monika Puzianowska‐Kuźnicka, Jan Naujoks, Leif Erik Sander, Martin Witzenrath, John C. Cambier, Norbert Suttorp, Ralf R. Schumann, Lei Jin, Thomas R. Hawn, Bastian Opitz, (unknown)	43
13	[Lipotourism, not without risks: a complication of cosmetic surgery abroad]. 2014 ·PubMed ·(unknown), Jakko van Ingen, (unknown), Annelies Verbon	5
14	Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study 2013 ·Immunity & Ageing ·(unknown), Evelien Pijpers, Nicole H. T. M. Dukers–Muijrers, Patty J. Nelemans, Christian J. P. A. Hoebe, Cathrien A. Bruggeman, Annelies Verbon, Valère J. Goossens	28
15	Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women 2013 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Mariëlle Beerepoot, Gerben ter Riet, S. Nys, (unknown), (unknown), Theo de Reijke, Jan M. Prins, (unknown), Annelies Verbon, Ellen E. Stobberingh, Suzanne E. Geerlings	3
16	Non–Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2 2004 ·American Journal of Respiratory and Critical Care Medicine ·Catharina W. Wieland, Sylvia Knapp, Sandrine Florquin, Alex F. de Vos, Kiyoshi Takeda, Shizuo Akira, Douglas T. Golenbock, Annelies Verbon, Tom van der Poll	43
17	Expression of Human Immunodeficiency Virus Coreceptors CXC Chemokine Receptor 4 and CC Chemokine Receptor 5 on Monocytes Is Down‐regulated during Human Endotoxemia 2002 ·The Journal of Infectious Diseases ·Nicole P. Juffermans, Sebastiaan Weijer, Annelies Verbon, Peter Speelman, Tom van der Poll	9
18	IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans 2001 ·The Journal of Immunology ·Annelies Verbon, Pascale E. P. Dekkers, Tessa ten Hove, C. Erik Hack, John P. Pribble, Terence Turner, Sonia Souza, Tim Axtelle, Frans J. Hoek, Sander J. H. van Deventer, Tom van der Poll	102
19	Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung 2000 ·American Journal of Respiratory and Critical Care Medicine ·Nicole P. Juffermans, Annelies Verbon, John T. Belisle, Preston J. Hill, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll	28
20	Tumor Necrosis Factor and Interleukin-1 Inhibitors as Markers of Disease Activity of Tuberculosis 1998 ·American Journal of Respiratory and Critical Care Medicine ·Nicole P. Juffermans, Annelies Verbon, Sander J. H. van Deventer, Henk van Deutekom, Peter Speelman, Tom van der Poll	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact